Pancreas Transplants | CMS Coverage Update

Summary: The Centers for Medicare & Medicaid Services modified its pancreas transplant coverage policy, effective May 15, 2026. Here's what billing teams need to do.

CMS pancreas transplant coverage policy has been updated for the first time in several years. This modification affects transplant centers, nephrology practices, and hospital billing teams that submit claims for pancreas transplant procedures under Medicare. The policy does not list specific CPT or HCPCS codes in the available data — we'll address what that means for your billing team below. Review your charge capture and prior authorization workflows before May 15, 2026.

Quick-Reference Table

CMS Pancreas Transplant Coverage Criteria and Medical Necessity Requirements 2026

Pancreas transplantation is one of the most tightly controlled procedures under Medicare. The Centers for Medicare & Medicaid Services has historically limited coverage to specific patient populations — and this modification signals a review of those limits.

The policy data available does not include a detailed summary of the specific criteria changes in this modification. That's a problem for billing teams who need to act before the effective date of May 15, 2026. Pull the full policy text directly from CMS or through your Medicare Administrative Contractor before making any assumptions about what changed.

What we know from longstanding CMS coverage policy on pancreas transplants: Medicare covers pancreas transplants performed simultaneously with a kidney transplant (simultaneous pancreas-kidney, or SPK transplant) as a standard covered benefit. Coverage for pancreas transplant alone (PTA) or pancreas after kidney (PAK) has historically been more restricted and subject to stricter medical necessity criteria.

Medical necessity for pancreas transplantation under Medicare generally requires a diagnosis of Type 1 diabetes mellitus with end-stage renal disease (for SPK), or evidence of life-threatening complications from diabetes management in patients who have already received a kidney transplant (for PAK). PTA coverage is the narrowest — CMS has required evidence of hypoglycemia unawareness, severe metabolic complications, or other clinical circumstances that make medical management unsafe.

If this modification changes any of those thresholds, your documentation requirements change too. Don't wait for a claim denial to find out what shifted.

Prior authorization is a factor in pancreas transplant billing. Medicare itself doesn't operate a traditional prior authorization system for inpatient surgical procedures the way commercial payers do, but transplant center certification and organ procurement requirements function as a form of pre-approval gatekeeping. Your transplant center must be CMS-certified. If certification status is not current, reimbursement will not follow regardless of how clean your claim is.

Talk to your compliance officer if you're uncertain how this modification applies to your transplant program's specific patient mix.

CMS Pancreas Transplant Exclusions and Non-Covered Indications

CMS has historically not covered pancreas transplantation for patients with Type 2 diabetes. This is a firm line in the coverage policy and a common source of claim denial for transplant programs that don't screen diagnoses carefully before submission.

Retransplantation following graft failure is another area where coverage has been uneven. CMS has required additional documentation of medical necessity for retransplant cases. If this modification addresses retransplantation criteria, your team needs to know before May 15, 2026.

Experimental protocols — including islet cell transplantation — remain outside standard Medicare coverage and are not addressed by this policy. If your program participates in any clinical trial involving islet transplantation, those claims follow a separate coverage determination pathway entirely.

Coverage Indications at a Glance

Note: The policy data does not include specific CPT, HCPCS, or ICD-10 codes. All indications above reflect longstanding CMS coverage policy on pancreas transplants. Verify specific coding requirements against the full policy text and your MAC's billing guidelines before May 15, 2026.

CMS Pancreas Transplant Billing Guidelines and Action Items 2026

This is where the lack of detailed policy data creates real operational risk. You can't update your billing process based on vague information. Here's what to do right now.

CPT, HCPCS, and ICD-10 Codes for Pancreas Transplants Under CMS Policy

The policy data for this modification does not include specific CPT, HCPCS, or ICD-10 codes. This is not unusual for CMS national policy modifications — the code-level detail often lives in the associated billing guidelines, MAC LCDs, or CMS claims processing instructions rather than the policy document itself.

Do not rely on this post for code selection. Pull the current CMS claims processing manual instructions and your MAC's billing guidelines for the definitive code list.

Commonly Associated Procedure Codes (Not Confirmed by This Policy Document)

For reference, pancreas transplant billing typically involves organ transplant procedure codes under the surgical range. However, because the policy data does not confirm which specific codes this modification covers, we are not publishing a code table here. Publishing unverified codes in a billing context creates more risk than it resolves.

Your coding team should cross-reference:

• The CMS IOM (Internet-Only Manual) for transplant billing instructions
• Your MAC's local coverage determination for any LCD that applies to pancreas transplants in your region
• The AMA CPT codebook for the current transplant surgery code range
• ICD-10-CM guidelines for diabetes mellitus and transplant status codes

If you need verified code-level guidance for this policy, your billing consultant or MAC coverage inquiry line is the right resource — not a blog post working from incomplete policy data.